WordNet

(medicine) the act of caring for someone (as by medication or remedial training etc.); "the quarterback is undergoing treatment for a knee injury"; "he tried every treatment the doctors suggested"; "heat therapy gave the best relief"
a glycoprotein secreted by the kidneys that stimulates the production of red blood cells

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. エリスロポエチン：皮下投与 erythropoietin subcutaneous administration
2. 透析前および腹膜透析患者における慢性腎疾患の貧血のためのエリスロポエチン erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients
3. 癌患者での貧血における赤血球生成刺激剤の役割 role of erythropoiesis stimulating agents in the treatment of anemia in patients with cancer
4. 血液透析患者での慢性腎疾患における貧血のためのエリスロポエチン erythropoietin for the anemia of chronic kidney disease in hemodialysis patients
5. 骨髄異形成症候群の合併症のマネージメント management of the complications of the myelodysplastic syndromes

Darbepoetin enhances endothelium-dependent vasomotor function in patients with stable coronary artery disease only after preceding ischaemia/reperfusion.

Tilling L, Hunt J, Donald A, Clapp B, Chowienczyk P.SourceBritish Heart Foundation Centre, Cardiovascular Division, Department of Clinical Pharmacology, King's College London, St Thomas' Hospital, London SE1 7EH, UK.
Clinical science (London, England : 1979).Clin Sci (Lond).2012 Apr;122(7):329-36.
Vasoprotective effects of erythropoietin in animal models are mediated by endothelium-derived NO and/or mobilization of EPCs (endothelial progenitor cells) and may be enhanced by ischaemia: whether they are present in humans is unknown. We examined whether the erythropoietin analogue darbepoetin imp
PMID 21966999

Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.

Yang J, Xiao Z, Li T, Gu X, Fan B.SourceDepartment of Neurosurgery, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, PR China.
International journal of oncology.Int J Oncol.2012 Apr;40(4):1230-7. doi: 10.3892/ijo.2011.1261. Epub 2011 Nov 11.
rhEPO is frequently used in clinical practice to treat anemia. However, recently rhEPO has been reported to accelerate tumor growth, progression and metastasis. Many pituitary adenoma patients, particularly those with macroprolactinomas, tend to have anemia and ma
PMID 22086127

今田直樹,奥原紀子,大西彰,平山きふ,関英夫,小山正樹,北村亮治,青木正
日本透析医学会雑誌 = Journal of Japanese Society for Dialysis Therapy
近年赤血球造血刺激因子（erythropoiesis stimulating agent：ESA）製剤投与中の血液透析患者におけるhemoglobin cycling（Hb cycling）という概念が注目されている．これはESA投与中の血液透析患者にみられる非生理的なヘモグロビン（Hb）値の周期的な変動であり，Hb値の変動が大きいほど入院，合併症，死亡のリスクが高く，血液透析患者の予後を悪化させ …
NAID 10029406030

大河原晋,鈴木昌幸,深瀬幸子,田部井薫
日本透析医学会雑誌 44(8), 675-680, 2011
… 血液透析（HD）症例を含めた慢性腎不全症例に認められる腎性貧血は相対的なerythropoietin産生低下とともに，赤血球脆弱性の関与も考えられているが，赤血球脆弱性に対するHDの影響に関する検討はいくつかの報告を認めるのみである．今回，維持HD症例12例を対象に，HD前後およびHD開始1時間後のdialyzer前後において，赤血球浸透圧脆弱性試験（osmotic fragility test）を施行し，赤血球osmotic fragilityに対するHDの影響，さらに …
NAID 130001014111